Lucosky Brookman Represents Castellum, Inc. in $4.5 Million Public Offering
Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government,…
Read MoreThe Latest News from Lucosky Brookman
Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions. Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here.
Lucosky Brookman Represents WestPark Capital in Shuttle Pharmaceuticals' $5.75 Million Public Offering
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on…
Read More
Brag House Holdings Successfully Completes $5.9 Million IPO with Legal Counsel from Lucosky Brookman
Brag House Holdings, Inc. (NASDAQ: BRAG), a pioneering media technology platform revolutionizing the casual college gaming experience,…
Read More
Lucosky Brookman Represents Capstone Holding Corp. in $5 Million Public Offering
Capstone Holding Corp. (NASDAQ: CAPS), a pioneering building products distribution company revolutionizing the construction materials sector,…
Read More
Lucosky Brookman Guides HeartBeam in Completed $10 Million Public Offering
HeartBeam, Inc. (NASDAQ: BEAT), a pioneering medical technology company revolutionizing cardiac care, has closed its $10 million public…
Read More
Lucosky Brookman Advises Titan Partners Group in Belite Bio's Strategic $15 Million Capital Raise
In a significant transaction for the biotechnology sector, Belite Bio, Inc (NASDAQ: BLTE) has secured $15 million through a registered…
Read More
Lucosky Brookman Represents R. F. Lafferty & Co. in ATIF Holdings Limited $2.5 Million Offering
ATIF Holdings Limited (NASDAQ: ZBAI), a Lake Forest-based business consulting firm specializing in IPO and M&A advisory services, has…
Read More
Pharmaceutical Innovator Virpax Secures $6 Million Financing with Lucosky Brookman and Spartan Capital
In a pivotal development for the pain management sector, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) has successfully raised $6 million through…
Read More
Lucosky Brookman Represents Quantum Computing Inc. in $100 Million Private Placement
Quantum Computing Inc. (NASDAQ: QUBT), an innovative integrated photonics and quantum optics technology company, has successfully closed a…
Read More
Lucosky Brookman Represents The Benchmark Company in DatChat's $5.1 Million Offering
DatChat, Inc. (NASDAQ: DATS), a secure messaging, social media, and metaverse company, has successfully closed a $5.1 million registered…
Read More